Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-21-028297
Filing Date
2021-08-13
Accepted
2021-08-13 17:06:12
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 ny20000330x1_s-3.htm S-3 253084
2 EXHIBIT 23.1 ny20000330x1_ex23-1.htm EX-23.1 2567
3 EXHIBIT 23.2 ny20000330x1_ex23-2.htm EX-23.2 2268
4 logo_brooklyn.jpg GRAPHIC 97422
5 logo_brooklynx1.jpg GRAPHIC 108257
  Complete submission text file 0001140361-21-028297.txt   542157
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258816 | Film No.: 211173250
SIC: 2834 Pharmaceutical Preparations